Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Entrada Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of TRDA: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders110107−3
Shares30.2M29.6M−658.0K (−2.2%)
Value$274.5M$198.8M−$75.7M (−27.6%)

New holders (22)

Institutions that held Entrada Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to TRDA in Q2 2025
InstitutionSharesValue% of portfolio
Royce & Associates LP223,251$1.50M0.02%
Millennium Management LLC170,322$1.14M0.00%
Jane Street Group, LLC51,158$343.8K0.00%
Corton Capital Inc.28,755$193.2K0.23%
Dynamic Technology Lab Private Ltd24,734$166.0K0.02%
Quantinno Capital Management LP18,622$125.1K0.00%
Walleye Capital LLC17,409$117.0K0.00%
Man Group plc16,805$112.9K0.00%
ExodusPoint Capital Management, LP15,785$106.0K0.00%
Squarepoint Ops LLC11,208$75.3K0.00%
IHT Wealth Management, LLC10,700$71.9K0.00%
Occudo Quantitative Strategies LP10,148$68.2K0.01%
Versant Capital Management, Inc1,464$9.84K0.00%
SRS Capital Advisors, Inc.465$3.13K0.00%
Skopos Labs, Inc.393$2.64K0.00%
Global Retirement Partners, LLC250$1.68K0.00%
Advisor Group Holdings, Inc.211$1.42K0.00%
Signaturefd, LLC53$3560.00%
True Wealth Design, LLC31$2090.00%
Clearstead Advisors, LLC13$880.00%
EverSource Wealth Advisors, LLC7$470.00%
Essential Partners LLC5$340.00%

Sold out (25)

Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.